Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cardiomyopathy
100%
Marfan Syndrome
100%
Abnormal muscle Response
100%
Mechanosignaling
100%
Fibrillin-1 (FBN1)
57%
Dilated Cardiomyopathy
42%
Angiotensin II Type 1 Receptor (AT1R)
42%
Cardiomyocytes
28%
Cardiac Dysfunction
28%
Integrin
14%
Stress-induced
14%
Extracellular Matrix
14%
Gene-deficient Mice
14%
Cardiac muscle
14%
Cardiac Function
14%
Receptor Signaling
14%
Myocardial Tissue
14%
Kinase Activity
14%
Physical Properties
14%
Multisystem Disease
14%
Extracellular Matrix Protein 1 (ECM1)
14%
Valvular Disease
14%
Angiotensinogen
14%
Mechanical Stress
14%
Arrestin
14%
Gene Inactivation
14%
Physiological Adaptation
14%
Haploinsufficient
14%
Focal Adhesion Kinase
14%
Fibrillin-1 Gene
14%
Spontaneous Emergence
14%
Angiotensin II Type 1 Receptor Antagonist
14%
Angiotensin-converting Enzyme Inhibitor (ACEi)
14%
Gene Encoding
14%
Cardiac Size
14%
Primary Manifestation
14%
Focal Adhesion Kinase Signaling
14%
Pharmacology, Toxicology and Pharmaceutical Science
Myocardial Disease
100%
Marfan Syndrome
100%
Fibrillin 1
71%
Receptor
42%
Congestive Cardiomyopathy
42%
Angiotensin II
42%
Focal Adhesion Kinase
28%
Janus Kinase 1
28%
Diseases
28%
Integrin
14%
Dipeptidyl Carboxypeptidase Inhibitor
14%
Angiotensinogen
14%
Retina S Antigen
14%
Matrix Protein
14%
Angiotensin 1 Receptor Antagonist
14%
Biochemistry, Genetics and Molecular Biology
Marfan's Syndrome
100%
Mechanotransduction
100%
Fibrillin
71%
Angiotensin II Receptor Type 1
42%
Cardiac Muscle Cell
28%
Janus Kinase 1
28%
Enzyme Inhibitor
14%
Angiotensin-Converting Enzyme
14%
Mechanical Stress
14%
Arrestin
14%
Integrin
14%
Heart Function
14%
Receptor Antagonist
14%
Gene Inactivation
14%
Heart Size
14%
Extracellular Matrix Protein
14%
Angiotensin
14%